Medtronic has secured a green light from the FDA to connect its latest automated insulin pump with its newest continuous ...

Medtronic (NYSE:MDT) announced that the FDA approved its Simplera Sync continuous glucose monitor for use with the.

The updated device allows users to pair the sensor with Medtronic’s insulin pumps, and is expected to grow the company’s ...

The US Food and Drug Administration (FDA) has granted approval for the use of Medtronic’s disposable Simplera Sync sensor ...

The NIM-Response® 3.0 and NIM-Neuro® 3.0 offer advanced nerve monitoring technology with an easy-to-use interface. NIM® systems monitor EMG activity from multiple mucles. If there is a change ...

Intraoperative NIM nerve monitoring systems enable surgeons to identify, confirm, and monitor motor nerve function to help reduce the risk of nerve damage during various procedures, including ENT ...

Medtronic (NYSE:MDT) recently announced the FDA approval for its Simplera Sync sensor, enhancing the MiniMed 780G system with ...